Skip to main content
Equibles

Verdad Advisers, LP

Position in CGEM — Cullinan Therapeutics, Inc.

CIK 1812822 BOSTON, MA
Back to CGEM Full portfolio

Position in CGEM

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$527,853
+$348,751 QoQ
Shares Held
28,987
+130.0% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.51%
of 13F equity value
Holder Rank
#94
of 183 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CGEM Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Verdad Advisers, LP holds $43,358,526 across 92 Biotechnology names. CGEM ranks #31 (1.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 BLTE
Belite Bio, Inc
 13,758 $2,118,525
2 ACAD
Acadia Pharmaceuticals Inc
 82,629 $2,090,513
3 TENX
Tenax Therapeutics, Inc.
 123,174 $1,792,181
4 ZYME
Zymeworks Inc.
 66,688 $1,743,224
5 XFOR
X4 Pharmaceuticals, Inc
 352,093 $1,644,274
6 WHWK
Whitehawk Therapeutics, Inc.
 301,483 $1,380,792
7 CTNM
Contineum Therapeutics, Inc.
 81,014 $1,327,819
8 JBIO
Jade Biosciences, Inc.
 56,384 $1,252,852

All Filings in CGEM

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $527,853 28,987
2026-03-31 $179,102 12,604